This is yet another study showing huge, astounding results using HCQ, (hydroxychloroquine) and zinc on Covid-19 patients.
"We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients," the study's conclusion states.
That's nearly three times the survival rate of the unmedicated patients in the study. You never see things like that in the medical literature. You see things like 10% improvement in survival. Ten percent is considered pretty good. Survival rate triple? You never see that. That's like a Royal Flush in poker.
Just a reminder, HCQ is banned for use on Covid-19 in Canada. Banned.
Okay? Are we learning yet?
Okay? Are we learning yet?
3 comments:
Everyone who could learn, did learn, before this, because the parking lots of American medical establishments within driving distance of Canada are always filled with Canadian license plates.
In the U.S. emergency-use authorization of a therapy cannot be granted if there's an effective treatment.
Canada-?
In Ontario we say it is better to crawl to Buffalo than end up in a Toronto hospital.
All I know about the HCQ situation here I learned from the local pharmacy, who said they're "not allowed" to dispense HCQ or Ivermectin for Covid-19. Plus they can't get any, it isn't available.
However I noticed the dog's heartworm pills are Ivermectin. Where there's a will, there's a way. Not a very good way, but if you're going to -die-...
Post a Comment